IPO Boutique Research, Color & More Information for Subscribers
2016 US IPO Market Analysis and Review A steep decline in the number of deals coming to market continued in 2016. Last year’s depressed number of 153 IPOs was cut by 34.6% as just 100 deals priced this past year. This total does not include SPACs or unit IPOs. Proceeds from all offerings (including SPACs)[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Aclaris Therapeutics, Inc. Symbol: ACRS Price: Last trade $22.86 Trade Date: 11/18 Shares: 2.8 million Underwriter(s)Jefferies, Leerink Partners, Guggenheim Securities CoManager(s)William[…]